A new analysis in Clinical Gastroenterology and Hepatology (Brenner et al., Sept 2025) examines geodemographic trends in private equity (PE) acquisitions of U.S. gastroenterology practices from 2013–2023. The study confirms that GI has become a prime target for PE investment, driven by its high-volume procedures, strong ancillary revenue streams, and outpatient consolidation opportunities. What was once an abstract trend is now local and visible, directly shaping daily GI practice across the country. The findings underscore how PE is reshaping practice ownership and care delivery in gastroenterology.
Trending
- Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer (Business Wire)
- Century Health and Arizona Gastrointestinal Associates Partner to Accelerate Real-World Evidence in IBD and MASH (PR Newswire)
- EF-YOLO: A novel AI model for high-precision detection of colorectal polyps (EurekAlert)
- Who’s winning, losing the physician practice acquisition race? (Becker’s Healthcare)
- Clinician-Industry Collaboration: A Clinical Review of Ethical, Strategic, and Practical Considerations (GI & Endoscopy News)
- Wanna Be Startin’ Somethin’? Advice for Initiating a New Line of Service (GI & Endoscopy News)
- The robotic penguin that makes endoscopy optional (Technology.org)
- Peptides, Colonoscopy, and the Inversion of Risk (Medscape)
